FDA Investigator Mark E Frank
Mark E Frank has conducted inspections on 5 sites in 1 countries as of 18 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
18 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Mark E Frank:
Andrew A Leboeuf,
Anthony F Lorenzo,
Antoinette L Chancey,
Brian D Nicholson,
Bruce H Mccullough,
Burnell M Henry,
CDR Sean T Creighton,
Chad E Schmear,
Christopher D Leach,
Clotia Cabbey Mensah,
Darrell E Luedtke,
David J Gasparovich,
David Perkins,
Debra I Love,
Denise L Burosh,
Dr. Gang Wang, PhD,
Eric M Mueller, PharmD,
Eric S Pittman,
Gregory R Dill,
Jacqueline Mdiaz Albertini,
James W Plucinski,
Jeanne J Chiu,
Jeanne M Morris,
Jesse A Vazquez,
Joseph A Morkunas,
Karen Emasley Joseph,
Kimberly Lewandowski Walker,
Kristen E Szenderski,
Kyran R Gibson,
Lauren A Crivellone,
Lequita M Mayhew,
Lorelei S Jarrell,
Maksim A Levenchuk,
Margaret Torres Vazquez,
Matthew J Sienko,
Michele L Glendenning,
Nicholas Z Lu,
Norman L Brown,
Norman Wong,
Paola S Barnett,
Patricia A Mcilroy,
Phung Thien Nguyen,
Prabhu P Raju,
Rachel T Evans,
Rafael Padilla,
Roberta W Cunningham,
Rose Ashley,
Rosemary Wood Sexton,
Russell K Riley,
Ryan Gibson,
Simone E Pitts,
Stephen D Eich,
Sullan,
Susan P Bruederle,
Tamara Brey,
That Q Dang,
Todd M Stankewicz
Mark E Frank's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2003 | FDA 483 | Baxter Healthcare Corporation - Form 483, 2003-03-03 |
March, 2003 | FDA 483 Response | Baxter Healthcare Corporation - Form 483R, 2003-04-07 |
March, 2003 | FDA 483 Response | Baxter Healthcare Corporation - Form 483R, 2003-03-20 |
March, 2003 | FDA 483 | Baxter Healthcare Corporation - Form 483, 2003-03-24 |
March, 2003 | EIR | Baxter Healthcare Corporation - EIR, 2003-03-24 |
March, 2003 | EIR | Baxter Healthcare Corporation - EIR, 2003-03-03 |
March, 2003 | FDA 483 | Medco Instruments Inc - Form 483, 2003-03-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more